Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
ABSTRACTEfficacy of cancer immunotherapies relies on correct recognition of tumor antigens by lymphocytes, eliciting thus functional responses capable of eliminating tumor cells. Therefore, important efforts have been carried out in antigen identification, with the aim of understanding mechanisms of...
Saved in:
Main Authors: | Belen Aparicio (Author), Patrick Theunissen (Author), Sandra Hervas-Stubbs (Author), Puri Fortes (Author), Pablo Sarobe (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting neoantigens for cancer immunotherapy
by: Xuan Zhao, et al.
Published: (2021) -
The Value of Microbes in Cancer Neoantigen Immunotherapy
by: Junrui Tian, et al.
Published: (2023) -
Current Trends in Neoantigen-Based Cancer Vaccines
by: Szu-Ying Ho, et al.
Published: (2023) -
The Paradoxes of Neoantigenes in Predicting Better Prognosis of Cancer Patients
by: Rui-An Wang, et al.
Published: (2016) -
Progress and challenges of personalized neoantigens in the clinical treatment of tumors
by: Hongyu Zhang, et al.
Published: (2020)